Report cover image

Strategic Intelligence: Pharma M&A Deals Q2 2025 - Top Themes

Publisher GlobalData
Published Jul 25, 2025
Length 24 Pages
SKU # GBDT20306659

Description

Strategic Intelligence: Pharma M&A Deals Q2 2025 - Top Themes

Summary

This report analyzes the disruptive themes that have driven M&A activity in Q2 2025 in the pharma Sector.

The global pharma sector in Q2 2025 witnessed deals worth $36 billion, a growth of 14% compared to Q2 2024. The Pharma sector recorded deal value worth $29 billion mega deals (defined as any deal valued at more than $1 billion) in Q2 2025, an increase of 51% compared to Q2 2024.

Scope
  • This report provides an overview of merger and acquisition activity globally in Q2 2025 in Pharma Sector
  • It identifies the themes driving most notable to deals announced in Q2 2025 in the Pharma Sector
Reasons to Buy
  • Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A).
  • In this report we have listed down the most notable deals in pharma sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.

Table of Contents

24 Pages
Executive Summary
Review of the Pharma M&A Market - Q2 2025
Pharma M&A Deals Analysis by Geography - Q2 2025
Further Reading
Appendix 1: Deal Selection Criteria
Appendix 2: Thematic Research Methodology

Search Inside Report

How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.